Alpha 2.0
Login Register
» Authors » D Piszkiewicz

D Piszkiewicz

Explore the profile of D Piszkiewicz including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 44
Citations 208
Followers 0
Related Specialties
Biochemistry
Science
Hematology
Top 10 Co-Authors
E L Smith
M Landon
R Apfelzweig
J G Moe
W Thomas
T C Bruice
O Gawron
C D Cabradilla
J S McDougal
H Kingdon
Published In
Biochemistry
J Biol Chem
J Am Chem Soc
Proc Natl Acad Sci U S A
Biochem Biophys Res Commun
Affiliations
Soon will be listed here.
Recent Articles
1.
Inactivation of HIV-2 by solvent/detergent treatment
Piszkiewicz D, Tondreau S
Transfusion . 1990 Feb; 30(2):192. PMID: 2305449
No abstract available.
2.
Inactivation and removal of human immunodeficiency virus in monoclonal purified antihemophilic factor (human) (Hemofil M)
Piszkiewicz D, Sun C, Tondreau S
Thromb Res . 1989 Sep; 55(5):627-34. PMID: 2510362
Cold supernatant which was prepared from factor VIII:C containing cryoprecipitate was seeded with HIV-1, then treated with a mixture of tri (n-butyl) phosphate (TNBP) and triton X-100. A greater than...
3.
Virus inactivation by heat treatment of lyophilized coagulation factor concentrates
Piszkiewicz D, Thomas W, Lieu M, Tse D, Sarno L
Curr Stud Hematol Blood Transfus . 1989 Jan; (56):44-54. PMID: 2491984
No abstract available.
4.
Inactivation of HIV in antithrombin-III concentrate by pasteurization
Piszkiewicz D, Apfelzweig R, Bourret L, Hattley K, Cabradilla C, McDougal J, et al.
Transfusion . 1988 Mar; 28(2):198-9. PMID: 3354052
No abstract available.
5.
Heat inactivation of human immunodeficiency virus in lyophilized factor VIII and factor IX concentrates
Piszkiewicz D, Bourret L, Lieu M, Hattley K, Thomas W, Cabradilla C, et al.
Thromb Res . 1987 Jul; 47(2):235-41. PMID: 3116716
No abstract available.
6.
Effect of screening for antibody to the human immunodeficiency virus and alanine aminotransferase on antibody content of intravenous immune globulin
Piszkiewicz D, Apfelzweig R, Janichen F
Transfusion . 1987 Jul; 27(4):367. PMID: 3474813
No abstract available.
7.
HTLV-III antibodies after immune globulin
Piszkiewicz D
JAMA . 1987 Jan; 257(3):316. PMID: 3467073
No abstract available.
8.
Immunoglobulin A concentrations in commercial immune globulins
Apfelzweig R, Piszkiewicz D, Hooper J
J Clin Immunol . 1987 Jan; 7(1):46-50. PMID: 3558735
Commercial immune globulins contain varying concentrations of IgA as a minor constituent. For patients who are both IgA deficient and IgA hypersensitive, the administration of most immune globulins is contraindicated...
9.
Safety of an intravenous immunoglobulin preparation: lack of seroconversion for human immunodeficiency virus antibodies
Lee M, Kingdon H, Hooper J, Courter S, Holst S, Piszkiewicz D
Clin Ther . 1987 Jan; 9(3):300-3. PMID: 3111704
A retrospective analysis of 18 patients who had received a human intravenous immunoglobulin (IGIV) preparation was undertaken to ascertain the safety of this preparation with respect to transmission of human...
10.
The incidence of HTLV-III/LAV seroconversion and non-A, non-B hepatitis in recipients of plasma products
Piszkiewicz D, Kingdon H, Lee M, Hooper J
Dev Biol Stand . 1987 Jan; 67:327-31. PMID: 2440745
Several groups including ours at Hyland have studied the incidence of HTLV-III/LAV seroconversion and non-A, non-B hepatitis (NANBH) in recipients of products made from unscreened plasma. Of 18 previously untreated...